A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Thermo Fisher Scientific Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
Thermo Fisher Scientific Shows Improved Relative Price Performance; Still Shy Of Benchmark Investor's Business Daily
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario - MedCity News
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario MedCity News
Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years - Yahoo Finance
Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years Yahoo Finance
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights - MedTech Intelligence
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights MedTech Intelligence
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal - Fierce Biotech
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal Fierce Biotech
Thermo Fisher to buy Clario for $8.8bn - Clinical Trials Arena
Thermo Fisher to buy Clario for $8.8bn Clinical Trials Arena
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion - Reuters
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion Reuters
Thermo Fisher Scientific to accelerate life science breakthroughs with OpenAI - SelectScience
Thermo Fisher Scientific to accelerate life science breakthroughs with OpenAI SelectScience
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B - MedTech Dive
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B MedTech Dive
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific - Latham & Watkins LLP
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific Latham & Watkins LLP
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights - Business Wire
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights Business Wire
WilmerHale Advises Thermo Fisher Scientific on $9 Billion Acquisition of Clario - WilmerHale
WilmerHale Advises Thermo Fisher Scientific on $9 Billion Acquisition of Clario WilmerHale
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - The Wall Street Journal
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion The Wall Street Journal
Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM - Business Wire
Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM Business Wire
Thermo Fisher nears $10 billion takeover of Clario, FT reports - Reuters
Thermo Fisher nears $10 billion takeover of Clario, FT reports Reuters
Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025 - Business Wire
Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025 Business Wire
Thermo Fisher Scientific (TMO): Assessing Valuation After Upbeat Q3 Results and Raised Outlook - Yahoo Finance
Thermo Fisher Scientific (TMO): Assessing Valuation After Upbeat Q3 Results and Raised Outlook Yahoo Finance
Thermo Fisher Scientific Launches Industry-First Orbitrap Mass Detector for Environmental and Food Safety Testing - Business Wire
Thermo Fisher Scientific Launches Industry-First Orbitrap Mass Detector for Environmental and Food Safety Testing Business Wire
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page